Literature DB >> 3124642

Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.

E Kawahara1, Y Oda, A Ooi, S Katsuda, I Nakanishi, S Umeda.   

Abstract

Immunoreactivity of glial fibrillary acidic protein (GFAP) in 38 schwannomas and 18 neurofibromas was evaluated and compared with the reactivity of vimentin, S-100 protein, and neurofilament protein. All cases were positive for vimentin and S-100 protein. GFAP was positively stained in the neoplastic cells of 15 of 38 schwannomas (38%) and in two of 18 neurofibromas (11%). The extensively stained GFAP-positive tumors tended to be deeply situated in the body. The GFAP-positive cells were usually spindle-shaped and appeared preferentially in the perivascular region of hyalinized, thick blood vessels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124642     DOI: 10.1097/00000478-198802000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

3.  The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.

Authors:  Anne-Marie Bashour; J-J Meng; Wallace Ip; Mia MacCollin; Nancy Ratner
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Cellular schwannoma. A clinicopathologic study of 29 cases.

Authors:  P Lodding; L G Kindblom; L Angervall; G Stenman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Immunochemistry of ethylnitrosourea-induced rat neurinomas, the RN6 neurinoma cell line and their transplantation tumors.

Authors:  K T Vogeley; T Bilzer; G Reifenberger; W Wechsler
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Aberrant axon neurofilaments in schwannomas associated with phacomatoses.

Authors:  Janine Wechsler; Laurent Lantieri; Jacques Zeller; Marie-Catherine Voisin; Nadine Martin-Garcia; Pierre Wolkenstein
Journal:  Virchows Arch       Date:  2003-09-24       Impact factor: 4.064

Review 7.  Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.

Authors:  Harish N Vasudevan; Calixto-Hope G Lucas; Javier E Villanueva-Meyer; Philip V Theodosopoulos; David R Raleigh
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

8.  The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.

Authors:  E Kawahara; M Shiroo; I Nakanishi; S Migita
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

9.  Benign retroperitoneal schwannoma presenting as colitis: a case report.

Authors:  Gary Fass; Didier Hossey; Michel Nyst; Dirk Smets; Esmail-Najar Saligheh; Ruth Duttmann; Kathleen Claes; Pierre-Mendes da Costa
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

10.  EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers.

Authors:  Michael Michal; Brian P Rubin; Abbas Agaimy; Kemal Kosemehmetoglu; Erin R Rudzinski; Konstantinos Linos; Ivy John; Zoran Gatalica; Jessica L Davis; Yajuan J Liu; Jesse K McKenney; Steven D Billings; Marián Švajdler; Olena Koshyk; Zdeněk Kinkor; Květoslava Michalová; Antonina V Kalmykova; Zarifa Yusifli; Nikola Ptáková; Veronika Hájková; Petr Grossman; Petr Šteiner; Michal Michal
Journal:  Mod Pathol       Date:  2020-10-04       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.